register

News & Trends - MedTech & Diagnostics

First dedicated cardiac hospital in the Southern Hemisphere to commence clinical services

Health Industry Hub | February 22, 2023 |

MedTech News: Australia’s first dedicated heart hospital has opened at Monash University’s Clayton campus. Cardiovascular care, world-class research and a significant healthcare workforce have combined in one place with the official opening of the Victorian Heart Hospital (VHH).

The $564 million facility operated by Monash Health accommodates 196 beds, seven catheterisation laboratories and one whole floor dedicated to heart research.

Monash President and Vice-Chancellor Professor Margaret Gardner AC joined Victorian Premier the Hon Daniel Andrews, Minister for Health the Hon Mary-Anne Thomas, and Monash Health Chief Executive Professor Andrew Stripp to celebrate the opening of the hospital. The first clinical services will commence from 23 February.

“The Victorian Heart Hospital is Australia’s first hospital dedicated to heart health in the Southern Hemisphere, where medical researchers, innovators, clinicians and health professionals of the future will work collaboratively to benefit patients and improve the heart health of communities throughout Australia,” Professor Gardner said.

“This means we can address the problem of heart disease in this country from all angles – from research-informed patient care and community-wide initiatives aimed at reducing risk factors, to educating and training students in cardiovascular care, providing placements and job opportunities.”

VIC Premier Daniel Andrews said “We are delivering the largest pipeline of health projects in our history – and the Victorian Heart Hospital will set new standards for cardiac care in Australia. The hospital will foster research that will benefit Victorians for generations to come, and help to train the amazing doctors, nurses and other professionals who work each day with such dedication.”

Operated by Victoria’s Monash Health, the VHH hosts the Monash Victorian Heart Institute (VHI) on a dedicated floor of the building. The Institute brings together world-leading cardiovascular experts, researchers, students and entrepreneurs who are focused on taking discoveries, techniques and therapies out of the lab and into practice.

“Hospital patients are able to access world-class cardiac care, delivered by Monash Health, and ground-breaking Monash University research all under one roof,” said Professor Stephen Nicholls, who is director of both the VHI and the VHH.

Professor Christina Mitchell AO, Monash University’s Dean of the Faculty of Medicine, Nursing and Health Sciences, said that through the VHI, cardiovascular undergraduate and postgraduate training courses in medicine, nursing and allied health are now located within the Heart Hospital, close to clinicians, practitioners and patients.

“Our students are able to apply their learning to real world challenges within the Heart Hospital, utilising simulation suites and learning spaces while working with the brightest researchers and clinical teams to improve clinical practice,” Professor Mitchell said.

The VHH is the latest addition to the expanding Monash Technology Precinct – Victoria’s largest employment hub outside of the CBD that hosts an innovation ecosystem of world-leading research facilities, companies and start-ups located in and around Monash University’s Clayton campus in Melbourne’s south east. The VHH is located across the road from the Australian Synchrotron, the Melbourne Centre for Nanofabrication, and Moderna’s new mRNA vaccine manufacturing facility, which is now under construction.

Other members of the Monash Technology Precinct include Biobanking Victoria, the CSIRO and Pfizer.

“The Monash Technology Precinct is a catalyst for collaboration and innovation, combining expertise, scale and research capability with the talent, enterprise and industry-backing that is needed to translate research and development into start-ups and commercial applications that can make a difference both locally and globally,” said Professor Gardner.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government's rejection of COVID Royal Commission a stark contrast to the UK and NZ

Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ

Health Industry Hub | September 20, 2024 |

The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]

More


News & Trends - Biotechnology

AusBiotech and MTPConnect Unite for Landmark Summit on Australia’s Biotech and Medtech Future

AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future

Health Industry Hub | September 20, 2024 |

AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]

More


ESG

Wear It Red Day ignites national movement for chronic pain recognition, demanding voices be heard

Wear It Red Day ignites national movement for chronic pain recognition, demanding voices be heard

Health Industry Hub | September 20, 2024 |

Today marks the first ever national Wear It Red Day. An initiative of Painaustralia, the national peak advocacy body for […]

More


News & Trends - Pharmaceuticals

Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients

Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study

Health Industry Hub | September 20, 2024 |

Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]

More


This content is copyright protected. Please subscribe to gain access.